tiprankstipranks
Trending News
More News >
Moleculin Biotech (MBRX)
NASDAQ:MBRX

Compare Moleculin Biotech (MBRX) vs. Competitors

Compare
1,917 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Moleculin Biotech
$4.59
$14.13M
-0.07
-88.95%
3 Buy
0 Hold
0 Sell
Strong Buy
Ibio
$2.15
$50.15M
-1.54
-27.36%
2 Buy
0 Hold
0 Sell
Moderate Buy
Inovio Pharmaceuticals
$1.61
$105.12M
-0.62
-20.69%
2 Buy
1 Hold
0 Sell
Moderate Buy
Akari Therapeutics
$0.28
$8.28M
-82.83%
3 Buy
0 Hold
0 Sell
Strong Buy
Lunai Bioworks
$0.84
$18.72M
-0.11
-88.99%
Tharimmune
$4.47
$160.10M
-1.14
124.62%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MBRX
Moleculin Biotech
4.28
-33.47
-88.66%
IBIO
Ibio
2.15
-0.86
-28.57%
INO
Inovio Pharmaceuticals
1.61
-0.48
-22.97%
AKTX
Akari Therapeutics
0.23
-0.86
-78.81%
LNAI
Lunai Bioworks
0.84
-6.66
-88.80%
THAR
Tharimmune
4.47
2.51
128.06%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts